2023 Annual Market Brand Analysis Report on Ultrasound Imaging Diagnostic Equipment
Market Overview and Data Sources
The year 2023 marks a continued development in China's medical equipment market, with ultrasound imaging diagnostic equipment being an important tool in the field of medical diagnosis. Its market performance directly reflects the demand for equipment updates by medical institutions and industry technology development trends. According to statistics from the authoritative market research agency mdbids, a total of 14,850 pieces of bidding data for ultrasound imaging diagnostic equipment were collected nationwide from January to December 2023, involving 5,567 purchasing units from medical institutions, 133 brand manufacturers, and 6,678 distributors. This large sample size fully demonstrates the activity level and competitive landscape of China’s ultrasound diagnostic equipment market.
From the perspective of market concentration, there is a clear head effect in the industry. The top five brands occupy a major share of the market: GE Healthcare (General Electric), Mindray Medical (Mindray), Philips (Philips), SonoScape Medical (SonoScape), and Siemens Healthineers (Siemens). These five leading international and domestic companies form the first tier in China's ultrasound diagnostic equipment market; their product performance, technological innovation capabilities, and marketing strategies directly influence the direction of industry development.
GE Healthcare Market Performance Analysis
Product Models and Market Share GE continues to maintain its leading position in China’s ultrasound diagnostic device market in 2023 as a global leader in medical imaging devices. Its product line covers everything from high-end flagship models to mid-range types with outstanding performances. Specifically speaking, Voluson E10 ranks first with a sales revenue share of 4.77%. This high-end ultrasound system designed specifically for obstetrics and gynecology has gained favor among numerous tertiary hospitals due to its excellent imaging quality and intelligent diagnosis functions. Following closely is LOGIQ E11 model which occupies a share of 2.63%. As another flagship product under General Electric's banner, E11 performs exceptionally well across cardiac care and abdominal applications. Ranking third is Voluson E8 which proves its enduring competitiveness within obstetric ultrasounds with a share of 2.06%. Together these three models constitute GE's core product matrix within China’s marketplace reflecting its technical accumulation and brand influence within high-end medical imaging devices. Distribution Characteristics Among Purchasing Units Analysis shows that GE's customer base exhibits diverse characteristics regarding purchasing units' distribution patterns where Suzhou Municipal Health Commission leads at first place accounting for about %0 .24% purchase ratio indicating advanced allocation capacity concerning healthcare resources throughout Yangtze River Delta region followed by Capital Medical University Affiliated Beijing Anzhen Hospital (%0 .22%) & Shaoguan City Qujiang District People's Hospital (%0 .18%). Such distributions encompass both top-tier tertiary hospitals along with grassroots-level healthcare facilities showcasing applicability across different levels’ health service providers alike. Notably amongst those ranked among Top-20 procurement entities include renowned Tertiary Hospitals such as Peking University First Hospital & Fudan University Zhongshan Hospital alongside lower-tier establishments like Kunshan Fourth People’s Hospital or Jishan County Medical Group indicating wide-ranging coverage suggesting differentiated marketing strategy implemented successfully enabling them meeting varying demands effectively across multiple tiers involved therein — this further affirms their capability fulfilling requirements efficiently irrespective whether it be elite institutions or community clinics alike! ... [Content truncated] ...